MedPath

Isoprenaline

Generic Name
Isoprenaline
Brand Names
Isuprel
Drug Type
Small Molecule
Chemical Formula
C11H17NO3
CAS Number
7683-59-2
Unique Ingredient Identifier
L628TT009W

Overview

Isoprenaline is a non-selective beta adrenergic receptor agonist indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion, congestive hear failure, and cardiogenic shock. Isoprenaline research in the 1940s found that this isopropyl analog of epinephrine dilated the bronchi, as well as raising the heart rate and cardiac output, without vasoconstriction. The US patent from 1943 states that this compound had a wider therapeutic index and a stronger action than adrenaline. Isoprenaline was granted FDA approval on 19 February 1948.

Background

Isoprenaline is a non-selective beta adrenergic receptor agonist indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion, congestive hear failure, and cardiogenic shock. Isoprenaline research in the 1940s found that this isopropyl analog of epinephrine dilated the bronchi, as well as raising the heart rate and cardiac output, without vasoconstriction. The US patent from 1943 states that this compound had a wider therapeutic index and a stronger action than adrenaline. Isoprenaline was granted FDA approval on 19 February 1948.

Indication

Isoprenaline is indicated to treat mild or transient episodes of heart block not requiring electric shock or pacemakers, serious episodes of heart block and Adams-Stokes attacks not caused by ventricular tachycardia or fibrillation, and bronchospasm during anesthesia. Isoprenaline is also indicated for cases of cardiac arrest until preferable treatments like electric shock and pacemakers are available. Isoprenaline is also indicated as an adjunct therapy to fluid and electrolyte replacement therapy in hypovolemic shock, septic shock, hypoperfusion, congestive heart failure, and cardiogenic shock.

Associated Conditions

  • Adams-Stokes attacks
  • Bradycardia
  • Bronchospasm
  • Cardiac Arrest
  • Cardiac electrical storm
  • Congestive Heart Failure (CHF)
  • Hypoperfusion
  • Septic Shock
  • Serious Heart Block
  • Shock, Cardiogenic
  • Shock, Hypovolemic
  • Short QT syndrome
  • Syncope
  • Torsades de Pointes
  • Transient Heart Block
  • Ventricular Arrhythmia
  • Beta blocker overdose
  • Mild Heart Block

FDA Approved Products

Isoproterenol Hydrochloride
Manufacturer:Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Route:INTRAVENOUS
Strength:0.2 mg in 1 mL
Approved: 2023/11/21
NDC:23155-661
Isoproterenol Hydrochloride
Manufacturer:Micro Labs Limited
Route:INTRAVENOUS
Strength:0.2 mg in 1 mL
Approved: 2022/11/14
NDC:42571-294
Isoproterenol Hydrochloride
Manufacturer:Amneal Pharmaceuticals LLC
Route:INTRAVENOUS
Strength:0.2 mg in 1 mL
Approved: 2023/02/22
NDC:70121-1604
Isoproterenol Hydrochloride
Manufacturer:STI Pharma LLC
Route:INTRACARDIAC, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Strength:1 mg in 5 mL
Approved: 2022/10/04
NDC:54879-039
ISOPROTERENOL
Manufacturer:Cipla USA Inc.
Route:INTRACARDIAC, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Strength:0.2 mg in 1 mL
Approved: 2024/01/14
NDC:69097-521

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath